Preetam Shah
CIK: 0001787403
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Discretionary Trading P&L
Holdings
Transaction History (4 total)
- Jul 16, 2026ELTX
Elicio Therapeutics, Inc.
Award(A)DirectStock Option (Right to Buy)
60.8K shares- - Feb 2, 2026ELTX
Elicio Therapeutics, Inc.
Award(A)Direct24K shares- - Apr 15, 2025ELTX
Elicio Therapeutics, Inc.
Award(A)DirectStock Option (Right to Buy)
191.6K shares- - Sep 30, 2024CDTX
Cidara Therapeutics, Inc.
Award(A)DirectEmployee Stock Option (right to buy)
130.1K shares-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Jul 16, 2026 |  ELTX Elicio Therapeutics, Inc. | Award(A) Stock Option (Right to Buy) | 60,833 | - | - | Direct |
| Feb 2, 2026 | ELTX Elicio Therapeutics, Inc. | Award(A) | 24,000 | - | $0 | Direct |
| Apr 15, 2025 | ELTX Elicio Therapeutics, Inc. | Award(A) Stock Option (Right to Buy) | 191,624 | - | - | Direct |
| Sep 30, 2024 |  CDTX Cidara Therapeutics, Inc. | Award(A) Employee Stock Option (right to buy) | 130,087 | - | - | Direct |
1-4 of 4 transactions
About Shah Preetam
Shah Preetam (SEC CIK 0001787403) files insider reports with the SEC as Officer of Elicio Therapeutics, Inc. (ELTX) and Chief Financial Officer of Cidara Therapeutics, Inc. (CDTX).
Signal8 holds 5 ownership filings by Shah Preetam (1 Form 3, 4 Form 4), filed between Oct 2, 2024 and Jul 17, 2026. Those filings report 4 transactions, from Sep 30, 2024 to Jul 16, 2026. Signal8's Form 4 history starts in Sep 2024.
The business address on Shah Preetam's filings is in BOSTON, MA.
Recent filings by Shah Preetam
Other insiders filing for Elicio Therapeutics, Inc. (ELTX)
- ADAMS JULIAN, Director
- Ashe Carol Gail, Director
- Chudnovsky Yekaterina, Director
- Nissenson Allen, Director
- RUFFOLO ROBERT R, Director
- WILSON KAREN J, Director